SOURCE: IG Living Magazine

IG Living Magazine

May 03, 2010 10:00 ET

IG Living! Magazine Launches Enhanced, Redesigned Website

Revamped Site Features Expanded Resources, Feature Articles, Upcoming Events and a Link to the Magazine's Facebook Page

TEMECULA, CA--(Marketwire - May 3, 2010) - IG Living! magazine has announced the debut of its newly redesigned website ( As the only magazine dedicated to patients who use immune globulin (IG) products and their care providers, IG Living has long been a definitive source of information and inspiration to those in the IG community.

Published by FFF Enterprises, Inc., the nation's most trusted distributor of biopharmaceuticals, IG Living is now in its fifth year of publication and continues to find new and innovative ways to reach its rapidly expanding audience. The magazine's enhanced website provides yet another platform for connecting readers with the content they seek.

"Our mission is to support the IG community through education, communication and advocacy," says editor-in-chief, Ronale Tucker Rhodes. "Our subscribers rely on IG Living's content for timely information about their medication, treatments, reimbursement issues and more. Our new website is easier to navigate, with expanded landing pages and streamlined access to the articles and features our readers want most."

Registration on the IG Living website provides free, unlimited access to a vast network of resources tailored to the IG community, including:

  • in-depth features about immune-mediated disease states, IG treatments, lifestyle-related issues, reimbursement and more
  • specialty news coverage of companies, research, clinical trials and products
  • professionals who answer your medical and reimbursement questions
  • community resources, such as organizations, disease state websites, studies and reports
  • complete cover-to-cover content of each issue of IG Living magazine

Earlier this year, IG Living launched its Facebook fan page (a link is prominent on the website's home page), and response to the page has been overwhelmingly favorable. In its first few months on Facebook, the magazine has garnered more than 350 fans and is currently campaigning to achieve its ambitious goal of acquiring 2,010 fans by the end of 2010.

IG Living reaches more than 25,000 readers every two months, including more than 19,000 physicians, nurses, case managers and other healthcare professionals involved in treating patients with IG products. For more information or to subscribe, visit

About IG Living

IG Living is the only magazine dedicated to patients who use immune globulin products and to their care providers. IG Living launched its first bimonthly issue in February-March 2006, with an initial distribution of 25,000 -- direct to patients and their physicians' offices. Regular features include such topics as product and manufacturer news, resources for healthy living, immune globulin treatment options, reimbursement and clinical trials. IG Living is published by FFF Enterprises, Inc.

About FFF Enterprises, Inc.

FFF Enterprises, Inc., a privately held corporation, is the largest and most-trusted distributor of plasma products, vaccines and other biopharmaceuticals in the U.S. Founded in 1988, FFF is celebrating its 22nd year with more than a billion dollars in annual sales and a flawless safety track record. FFF's Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to licensed healthcare providers, protecting patients and manufacturers from counterfeit risks and pricing irregularities inherent in secondary and gray market channels. FFF's proprietary services, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel. FFF's MyFluVaccine ( has revolutionized the flu marketplace, offering a dedicated flu vaccine supply, delivered to customers on the date of their choosing. FFF's ability to move rapidly in a dynamically changing marketplace allows the creation of new opportunities for customers through innovative vehicles for distribution.

Contact Information